Agenus (AGEN) Enterprise Value (2010 - 2026)
Agenus' (AGEN) quarterly Enterprise Value came in at -$41.8 million in Q1 2026, down 4440.75% year-on-year from $962000.0 in Q1 2025, and down 328.38% quarter-over-quarter from -$9.7 million in Q4 2025.
Agenus (AGEN) Enterprise Value (2010 - 2026) Analysis & Trends
Agenus' Enterprise Value history runs 17 years deep, the most recent figure standing at -$41.8 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 4440.75% year-over-year to -$41.8 million in Q1 2026; TTM through Mar 2026 was -$41.8 million, a 4440.75% decrease from a year earlier, with the FY2025 full-year figure at -$9.7 million, up 52.4% from the prior year.
- Enterprise Value fell to -$41.8 million in Q1 2026 per AGEN's latest filing, from -$9.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at $8.8 million in Q2 2025 and bottomed at -$250.8 million in Q1 2022.
- The 5-year median for Enterprise Value is -$64.2 million (2023), against an average of -$92.3 million.
- Across the five-year window, Enterprise Value surged 111.96% in 2025 and sank 4440.75% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$187.0 million in 2022, then soared by 65.69% to -$64.2 million in 2023, then soared by 68.08% to -$20.5 million in 2024, then surged by 52.4% to -$9.7 million in 2025, then sank by 328.38% to -$41.8 million in 2026.
- Per Business Quant, the three latest AGEN Enterprise Value figures stand at -$41.8 million (Q1 2026), -$9.7 million (Q4 2025), and -$10.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -41.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.76 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -10.19 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 962,000.00 |
| Dec 31, 2024 | -20.48 Mn |
| Sep 30, 2024 | -24.25 Mn |
| Jun 30, 2024 | -73.25 Mn |
| Mar 31, 2024 | -41.75 Mn |
| Dec 31, 2023 | -64.16 Mn |
| Sep 30, 2023 | -92.49 Mn |
| Jun 30, 2023 | -141.42 Mn |
| Mar 31, 2023 | -183.81 Mn |
| Dec 31, 2022 | -186.98 Mn |
| Sep 30, 2022 | -209.68 Mn |
| Jun 30, 2022 | -228.11 Mn |
| Mar 31, 2022 | -250.76 Mn |
| Dec 31, 2021 | -293.45 Mn |
| Sep 30, 2021 | -267.83 Mn |
| Jun 30, 2021 | -82.18 Mn |